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Abstract
Real-time vaccination following an outbreak can effectively mitigate the damage caused by an
infectious disease. However, in many cases, available resources are insufficient to vaccinate the
entire at-risk population, logistics result in delayed vaccine deployment, and the interaction be-
tween members of different cities facilitates a wide spatial spread of infection. Limited vaccine,
time delays, and interaction (or coupling) of cities lead to tradeoffs that impact the overall
magnitude of the epidemic. These tradeoffs mandate investigation of optimal strategies that
minimize the severity of the epidemic by prioritizing allocation of vaccine to specific subpopu-
lations. We use an SIR model to describe the disease dynamics of an epidemic which breaks
out in one city and spreads to another. We solve a master equation to determine the resulting
probability distribution of the final epidemic size. We then identify tradeoffs between vaccine,
time delay, and coupling, and we determine the optimal vaccination protocols resulting from
these tradeoffs.
Introduction
Upon the outbreak of infectious disease, effective and widespread intervention through vaccina-
tion is of immediate concern. However, distributing and deploying vaccine relies on numerous
logistical or even political factors that can result in delays. Meanwhile, the extensive modern
network of rapid transportation facilitates the spread of infectious disease between communities.
If the resources available are insufficient to fully immunize the entire population, strategically
allocating vaccine to specific subpopulations can minimize the spread and severity of infection.
The interaction between members of different cities and the time delay until vaccination lead to
tradeoffs that can dictate optimal strategies of distributing limited vaccine. Optimizing resource
allocation is of great interest to policymakers who must decide who gets vaccinated and when.
Real-time vaccination after an outbreak has occurred necessarily involves delays resulting
from the production, testing, and/or delivery of vaccine. Such time delays can change the vaccine
allocation strategy which results in the fewest infections, in addition to greatly impacting the
severity of the epidemic. During the 2009 H1N1 influenza outbreak, a widespread vaccination
campaign in the United States successfully prevented between 0.7 and 1.5 million cases. However,
had the campaign started one week earlier, it is estimated that approximately 27% more cases
could have been prevented, and had the campaign begun two weeks earlier, approximately 59%
more cases could have been prevented [1].
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In some cases, stockpiles of vaccine have been established to expedite emergency interven-
tion, but there still remain time delays between the initial outbreak and widespread control.
For example, the International Coordinating Group (ICG) on Vaccine Provision for Epidemic
Meningitis Control, a collaboration between the World Health Organization, UNICEF, Me´decins
Sans Frontie`res, and the International Federation of the Red Cross, stockpiles meningococcal
vaccines as an emergency control method [2]. However, before deployment of stockpiled vaccines,
the government or organization in need must first submit a request to the ICG, which then ap-
proves or disapproves the request within 48 hours; procurement and delivery of vaccine takes up
to another 7 days. Furthermore, a multinational cooperative effort to undertake precautionary
measures is not readily established [3]. Developed nations usually have the means to produce
and stockpile large quantities of vaccines for themselves in preparation for an epidemic, but
developing nations often rely on vaccines donated by developed nations or acquired in exchange
for virus samples. In the case of the 2009 H1N1 epidemic, developed and developing nations
did not successfully broker a vaccine-sharing deal in time. Moreover, some nations which have
established stockpiles may keep vaccines for themselves during an epidemic. Fearing shortages at
home, some nations may delay exporting their stockpiled vaccines (or refuse to export outright),
another source of the time delay that hinders efficient, effective epidemic control [3].
In this paper, we use an SIR model to simulate the spread of infection and the effects of
real-time vaccination. Commonly used in epidemiology, the SIR model divides a population
into three compartments (susceptible S, infected I, and recovered R) with absorbing transitions
between states S and I and I and R [4]. Most SIR models are formulated as deterministic
mean-field theories consisting of coupled differential equations, especially when vaccination is
taken into account, since this can significantly complicate the model and increase computational
intensity. Stochastic models, on the other hand, take into consideration the variability of the final
epidemic size as well as the nonzero probability that infection fails to spread even in interacting
communities.
To investigate the disease dynamics, we utilize a discrete stochastic model complementary to
the deterministic approach. Our stochastic model serves as a critical check on the conclusions
drawn from the deterministic model. If an outbreak occurs within the deterministic model,
without intervention, the infection will eventually spread to every population which interacts
with the source of the infection. On the other hand, stochastic effects increase the temporal
uncertainty in infectious spread between cities, and the disease may completely fail to spread
from one city to another.
Rather than proactive (or prophylactic) vaccination, we focus on reactive vaccination ad-
ministered after the initial outbreak. The real-time response interacts with the dynamics of the
epidemic, ultimately impacting the final outcome. The disease dynamics in interacting popu-
lations are not necessarily synchronous; infection can be spreading throughout one city while
it is dying out in another. Simulating reactive vaccination is more computationally intensive
than prophylaxis, necessitating limited population sizes in our simulations, since the state of the
system must be determined at intermediate points during the epidemic, rather than simply the
final end state.
In this paper, we first investigate the spread of disease within an individual population and
identify tradeoffs between the amount of available vaccine and the time delay until vaccine is
administered. We then examine the spread of infection between two interacting cities linked
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via implied transportation routes, and we investigate how coupling, vaccine, and time delay
contribute to tradeoffs which in turn determine optimal vaccine allocation strategies. Finally,
we compare the optimal protocols with those of the deterministic case, and we determine the
differences between the optimal and worst-case scenarios.
Methods
SIR Model
In order to explore the temporal dynamics of an epidemic and investigate the effects of in-
tervention methods, we utilize the mathematical framework of the SIR model [4], which has
been commonly applied to infectious diseases such as influenza [5], measles [6], and whooping
cough [7]. In its simplest form, the SIR model divides a population of N individuals into three
compartments, S, I, and R, representing susceptible, infected, and recovered, respectively. A
susceptible individual becomes infected only through contact with an infective, and an infec-
tive, once recovered, develops an immunity to the disease, thus permanently remaining in the
recovered state.
The processes of infection and recovery can be described as an analog to two chemical
reactions, denoted Z1 and Z2, with reaction rates β and γ, respectively:
Z1 : S + I
β
−→ 2I,
Z2 : I
γ
−→ R.
(1)
Assuming a well-mixed population (i.e. an individual has equal probability of interaction
with every other individual), coupled, ordinary differential equations can be used to describe
the epidemic [8]:
dS
dt
= −βSI, (2)
dI
dt
= βSI − γI, (3)
dR
dt
= γI. (4)
Susceptible individuals become infected at rate β, and infected individuals recover at rate γ. The
last equation can be omitted if N is kept fixed, and R can be deduced from R(t) = 1−S(t)−I(t).
The infection rate β is defined as the product of the average number of contacts each indi-
vidual makes per unit time, c, and the probability of infection via contact, p, divided by the
total population size, N [8]:
β =
contact rate× probability of infection
total population size
=
cp
N
. (5)
The recovery rate γ is simply the inverse of the characteristic timescale over which an individual
remains infected T :
γ =
1
average infection duration
=
1
T
. (6)
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We also define the reproductive number r0, which represents the average number of in-
dividuals that will be infected by a single infective in a population completely consisting of
susceptibles [8]:
r0 ≡
βS0
γ
=
cpTS0
N
. (7)
where S0 = S(t = 0), the initial fraction of susceptibles. If r0 < 1, then in the deterministic
model, dI
dt
< 0; hence, the number of infectives declines from the individual value and no epidemic
will occur. The value of r0 varies greatly depending on the disease; r0 is approximately 1.7 for
influenza [5] and approximately 17 for measles and whooping cough [9].
Stochasticity and the Master Equation
Epidemics are not continuous processes, since S, I, and R levels can only change by discrete
integer values. Deterministic models are typically continuous mean-field theories that, unlike
stochastic models, do not account for variability in epidemic sizes. When populations are weakly
coupled, stochasticity can result in epidemics spreading from host cities to uninfected cities over
a longer time frame than in purely deterministic models [9]. Furthermore, stochastic models
include the nonzero probability that the epidemic does not progress. The probability distribution
of the cumulative number infected at asymptotically infinite time is typically bimodal, with one
peak representing a large-scale epidemic, and one peak representing the failure of the infection
to significantly spread. Moreover, in a discrete stochastic model, positive integer numbers of
individuals must make contact in order to transmit disease, while a continuous deterministic
model does not include this requirement.
In this paper, we model epidemics as semi-Markovian processes and investigate the role of
stochasticity in epidemics in coupled cities. The time evolution of the probability distribution is
described by a master equation. Defining P(S,I) = P(S,I)(t) as the probability of being in state
(S, I) at time t, the SIR master equation takes the form [9]:
dP(S,I)
dt
= β(S + 1)(I − 1)P(S+1,I−1)
+ γ(I + 1)P(S,I+1) − (βSI + γI)P(S,I).
(8)
The first term on the RHS represents a transition into state (S, I) by a susceptible individual
becoming infected; the second term represents a transition into state (S, I) by an infected indi-
vidual recovering; and the third term represents leaving the state (S, I) by infection or recovery.
Only one reaction can occur in each infinitesimal time interval [t, t+ dt].
The master equation is linear and can be written in matrix form with a column vector
~P containing probabilities of all possible states and a transition rate (or generator) matrix A
containing the coefficients of Eq. 8:
d~P
dt
= A~P . (9)
Rather than calculating ~P by counting S and I levels, we follow the “degree of advancement”
(DA) process [10] and count the occurrences of the Z1 and Z2 reactions described in Eq. 1. The
vector ~P (t) is composed of probabilities of each possible state (Z1, Z2), which represent the
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number of times each reaction has occurred in the time interval [0, t). If a population contains
S0 and I0 initial susceptibles and infectives, then Z1 can occur a total of S0 possible times, and
Z2 can occur up to S0 + I0 times. The DA process is preferred over the so-called “population
process” of counting population levels since the population levels at a given time can always be
determined from the number of reactions that have occurred, but not vice versa. Specifically,
X(t) = X(0) + SZ(t), (10)
where X is a column vector with population levels of all population classes, Z is a column
vector counting occurrences of all reactions, and S is a matrix composed of the stoichiometric
coefficients from Eq. 1. The components of ~P are ordered lexicographically, resulting in a lower
triangular generator matrix A, since the reactions of infection and recovery cannot be reversed.
Furthermore, due to the abundance of inaccessible states, A is a sparse matrix.
To numerically integrate the master equation, we use an algorithm recently devised by Jenk-
inson and Goutsias [10] known as the implicit-Euler, or IE, method. The IE method takes
advantage of the sparsity of A to achieve computational efficiency. We first discretize time into
integer multiples of a time step τ . Given specified initial conditions ~P (0), we can recursively
solve the system of linear equations
(1− τA)~P (ti) = ~P (ti−1). (11)
This is implemented in MATLAB.
In addition to the IE method, the stochastic SIR model is also frequently applied in direct
Monte Carlo simulations [11] [12], of which many repeated runs must be performed to obtain
a probability distribution. In contrast, solving the master equation generates a full probability
distribution at once for a chosen set of initial parameters. Moreover, it is also possible to arrive at
the steady-state probability distribution without the need for iterative integration of the master
equation [13] [14]. However, because we simulate real-time vaccination, we need to obtain the
probability vector at intermediate points during the epidemic, before the final steady state is
reached.
While the IE method can generate the full probability distribution at every time step with
high temporal resolution, it requires much more computation time than solving a set of deter-
ministic equations, realizing a direct Monte Carlo simulation, or acquiring the final steady-state
probability distribution. Hence, we consider relatively small system sizes in this paper, espe-
cially in the case of two coupled populations, where the number of reactions doubles compared
to a system of one individual population.
In individual populations, the number of possible states, and thus the dimension of the
generator matrix, is (S(0) + I(0) + 1)(S(0) + 1). Thus, for I(0) << S(0), the matrix dimension
approximately scales as N2. For multiple interacting populations, the number of possible states
becomes
M∏
i
(Si(0) + Ii(0) + 1)(Si(0) + 1),
whereM is the total number of populations. Therefore, for two coupled populations, the matrix
dimension scales as N4.
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While the two coupled populations in our simulations may be small, they can represent real-
istic communities such as classrooms, groups of households or families, or small neighborhoods.
Furthermore, the critical effects of temporal variability and non-transmission present in stochas-
tic but not deterministic models also occur for much larger populations, which can represent
entire cities or nations.
We initialize our simulations with specified numbers of susceptibles S0 and infectives I0, the
reproductive number r0, and the recovery rate γ. The infection rate β is calculated from r0 and
γ. At t = 0, the system is in state (0, 0) with probability 1; that is, the first element of ~P (0) is
1 with all others zero.
The severity of the epidemic is quantified by the mean final epidemic size 〈E〉 [8], defined
as the total population minus the mean number of susceptibles remaining at the end of the
epidemic. This represents the number of people who have been infected and then recovered, as
measured at in the limit of infinite time:
〈E〉 = lim
t→∞
N − 〈S(t)〉 . (12)
For our parameters, a simulation end time of 200 days was a sufficient approximation. In the
deterministic model, the final epidemic size is exact, as is the number of remaining susceptibles.
The probability distribution P (E) of final epidemic sizes E (Fig. 1) is observed to be bimodal
for large N and reproductive number r0 > 1, as is characteristic of stochastic epidemic models
[15]: either a few individuals or a majority of the population become infected in the most
likely scenarios. Fig. 1 illustrates the probability distribution for a simulation of one population
containing 100 initial susceptibles, 1 initial infective, where the recovery rate γ = 0.15 and
the reproductive number r0 is varied between 0.5 and 10. The leftmost peaks are located at
1, the number of initial seed infectives, and represent the case in which very few individuals
beyond the seed infective are infected, while the majority of the population remains susceptible.
We denote this the terminal infection case [8]. The rightmost peaks represent the large-scale
epidemic case, in which the infection spreads throughout a large portion of the population. The
deterministic outcomes are plotted as dashed lines and fall slightly to the left of the centers of the
epidemic peaks. At large values of r0, the large-scale epidemic peaks become taller and sharper;
as r0 decreases, the tails broaden, and the peaks are smaller. The terminal infection peaks are
taller for lower values of r0, since the probability of terminal infection for a fully susceptible
population seeded with one infective is equal to 1/r0 [9]. For large N , when r0 approaches unity,
the distinction between the terminal infection and large-scale epidemic peaks disappear.
Coupled Populations
Due to the widespread network of transportation between cities, it is difficult for an outbreak
of infectious disease to remain contained within one geographic location. Studying epidemics in
isolated communities can still provide important insights; for example, abundant historical data
on epidemics in the relatively isolated Faroe Islands have contributed to a rich understanding
of the spatial spread of measles, whooping cough, and mumps [16]. However, in this paper, we
focus on the dependence of the severity of infection and the optimal vaccination protocol on the
degree of interaction between cities.
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Figure 1. Probability distribution of final epidemic size. The distribution P (E) is
plotted for a population of 100 initial susceptibles and 1 infective in the stochastic model. The
recovery rate γ is set to 0.15 and the reproductive number r0 is varied between 0.5 and 10.
The corresponding deterministic outcomes are represented by dashed lines.
We model the epidemic as occurring in two cities connected via transportation routes that
allow individuals from one city to interact with those in the other, but where the total number
of residents in each city does not change. This can be thought of as a system of commuters,
where the degree of interaction, or coupling, between the cities is proportional to the time a
commuter spends outside their home city. We consider the specific case in which an epidemic
breaks out in one city and spreads to another. We seed one city, denoted city A, with one seed
infective, while the other city, city B, contains only susceptibles.
For two coupled cities, there are now a total of four possible reactions, denoted Z1, Z2, Z3,
and Z4:
Z1 : (SA, IA, SB , IB)→ (SA − 1, IA + 1, SB , IB),
Z2 : (SA, IA, SB , IB)→ (SA, IA, SB − 1, IB + 1),
Z3 : (SA, IA, SB , IB)→ (SA, IA − 1, SB , IB),
Z4 : (SA, IA, SB , IB)→ (SA, IA, SB , IB − 1).
(13)
A susceptible in one city can be infected by someone in either city; once infected, the susceptible
becomes an infective of its own city.
In the stochastic model, the probability vector ~P consequently comprises probabilities of
cumulative occurrences of the reactions in Eq. 13, (Z1, Z2, Z3, Z4), ordered lexicographically.
Our model also assumes homogeneous mixing within each city; that is, an individual in one city
has the same probability of interacting with another individual in the same city, and the same
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probability of interacting with all individuals in the other city. While we abstract geographic
details in our model, a distance-dependent kernel can be introduced to construct a more realistic
model. That is, a function that decays with distance can be multiplied with the infection rate
β, so that two individuals with greater spatial separation will be less likely to interact.
The coupling between the cities is characterized by a symmetric 2 × 2 matrix f , where fij
is the fraction of contacts an individual in city i makes that are residents of city j [17]. Each
row and column of f sums to 1. Thus, we denote the coupling between city A and city B as
fAB = fBA. The rate of infection β then becomes a 2× 2 matrix with elements
βij =
cpfij
Nj
. (14)
The corresponding deterministic equations that describe this model are
dSA
dt
= −βAASAIA − βABSAIB, (15)
dSB
dt
= −βBASBIA − βBBSBIB , (16)
dIA
dt
= βAASAIA + βABSAIB − γIA, (17)
dIB
dt
= βBASBIA + βBBSBIB − γIB . (18)
If coupling between the two cities is low, it is possible that the infection does not spread at
all from city A to city B in the stochastic model. The probability of an epidemic in city B is
given by [9]:
P(infection spreading from A to B) =
1− exp
(
−βBA
[
1−
γ
(βBA + βBB)
] ∫
∞
0
IA(s)ds
)
< 1− exp(−βBA/γ).
(19)
In both models, there exists a lag between the peaks of the infections (i.e. where the number
of infectives as a function of time I(t) reaches a maximum) in the two cities. In the stochastic
model, the lag time has a high variability, but on average is larger than the deterministic value
due to the decreased probability of transmission. In the deterministic model, if the two cities
have nonzero coupling, then the infection is present in city B at the start, and the lag time is
generally shorter. Unlike in the stochastic model, discrete integer values of infectives are not
required to make contact in order for infection to spread. In the early stages of infection, when
the number of susceptibles in city B is large and nearly constant, the number of infectives in
city B grows exponentially at a rate βBB − γ [9].
Vaccination
One major objective of vaccination is to approach “herd immunity”, which occurs when a critical
fraction of the population is vaccinated such that the effective reproductive number reff drops
below 1, thus preventing the epidemic from growing. If V individuals are vaccinated, the effective
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reproductive number is reff = r0(1 − V/S0). Hence, the minimum number of individuals that
must be vaccinated to induce herd immunity is S0(1− 1/r0).
Previous studies have utilized stochastic models to optimize vaccine allocation, but have
largely focused on prophylaxis [8] [18], rather than real-time vaccination, to which primarily
deterministic models have been applied [5] [19] [20] [21]. In this paper, we determine the optimal
allocation of vaccine, delivered in real time, for varying delay periods, coupling, and amounts of
available vaccine.
The optimal protocol is determined by minimizing the expected final epidemic size with
respect to the fraction of vaccine allocated to each city. Only susceptibles are vaccinated in our
simulations. The vaccines have 100% efficacy and are delivered in discrete amounts. Further-
more, vaccines are released all at once on a specified time step. At this vaccination time step,
the generator matrix is modified so that the transition rates reflect the new reduced number
of susceptibles. First, a sparse generator matrix for a system containing the new population
levels is computed and mapped to the dimensions of the original matrix. However, this does not
account for the probability that the system is in certain states that, while previously accessible,
are rendered newly inaccessible upon vaccination. For instance, consider a population initially
containing two susceptibles and one infective. If allowed to evolve without intervention, it is
possible for the two susceptibles to become infected, such that there are now three infectives.
That is, the probability vector ~P is non-zero for the Z1 = 2, Z2 = 0 state. If we vaccinate both
susceptibles at some time step, the system cannot transition to a state of higher infection, but
should be allowed to transition out of this (2, 0) state through recovery, i.e. to states (2, 0),
(2, 1), (2, 2), and (2, 3). Therefore, terms are added to the new generator matrix to reflect this.
Results
Time delays in reactive vaccination are inevitable. Factors such as logistics, spatial separation,
and limited availability of vaccine prevent the populace from receiving vaccination immediately
upon the outbreak of infection. Vaccine stockpiles can mitigate but not fully eliminate this time
delay. Furthermore, delayed efficacy of vaccines can also contribute to a delay between outbreak
and immunity of vaccinated susceptibles. Within an individual population, when time delay is
low, the amount of vaccine required to keep the average epidemic size below a bounded value
increases roughly exponentially with time delay. However, for large enough time delay, any
increase in vaccine will not affect the final epidemic size, since the infection will have already
spread to the entire population.
When individuals from two populations interact, coupling also contributes to tradeoffs, along
with the amount of available vaccine and the time delay. In general, when coupling is very low,
the optimal strategy tends to disparately favor one city over another, an effect that is less
prominent as time delay increases. If coupling is high, the cities are more well-mixed, and the
optimal protocol usually allocates vaccine to each city in proportional amounts.
We first investigate the spread of an arbitrary disease with r0 = 2 and γ = 0.15 through an
individual, non-interacting population of 100 initial susceptibles and one initial infective. With
spatial, logistical, and technical details abstracted, we identify tradeoffs between the amount of
available vaccine and the time delay until vaccine is administered. We then examine the spread
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of this disease from the host city, city A, to an initially infection-free city, city B. Due to the
computational intensity of the IE method, we focus on a system of two cities of 40 individuals
each, all susceptible except for one seed infective in city A. We then investigate how coupling,
as well as vaccine and time delay, contributes to tradeoffs, and we identify the optimal vaccine
allocation protocols which minimize the final epidemic size. We also examine the “worst-case
scenarios” which result when the final epidemic size is maximized, since common epidemic
control strategies, such as prophylaxis, can result in a mathematically non-optimal scenario. We
compare the optimal strategies with the worst-case protocols to determine where intervention
has the most significant payoffs.
Tradeoffs between Time Delay and Available Vaccine
The tradeoff between time delay, denoted τ , and available vaccine in a single population is illus-
trated in Fig. 2, which shows contours of final epidemic size plotted as a function of vaccination
and time delay for both the stochastic model (Fig. 2A) and the deterministic model (Fig. 2B).
The amount of vaccine is expressed as the fraction of the total population which is vaccinated.
The simulation is run on a population of 100 initial susceptibles and 1 seed infective, with re-
productive number r0 = 2.0 and recovery rate γ = 0.15. The deterministic results approach
a final epidemic size of approximately 70 individuals at day 50, compared to a mean final size
of approximately 35 individuals in the stochastic model. The epidemic is more severe in the
deterministic model than in the stochastic model since the deterministic model does not require
discrete integer values of individuals to make contact, thereby facilitating the infectious spread.
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Figure 2. Tradeoffs between time delay and available vaccine represented by
contours of final epidemic size. The mean final epidemic size in the stochastic model 〈E〉
(panel A) and the exact final epidemic size in the deterministic model Edet (panel B) are
plotted as a function of time delay τ (in days) and fraction of total population vaccinated.
Both models contain 100 initial susceptibles, 1 initial infective, γ = 0.15, and r0 = 2.
However, the contours in the two plots are similarly shaped. For both models, early in the
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epidemic, a smaller amount of vaccine is sufficient to contain the outbreak, but as time delay
increases, more and more vaccine is required to prevent the epidemic from growing beyond
a certain size. For τ below about 20 days, the contours are approximately linear in semi-
logarithmic space; that is, the vaccination rate must increase roughly exponentially with time
delay to keep the final epidemic size bounded below a certain value. Eventually, if time delay is
great enough, any increase in the amount of vaccination will be ineffective in reducing epidemic
size, as evidenced by the rapidly increasing, nearly vertical contours. This transition between
regimes is more abrupt in the stochastic model, for which the contours sharply become essentially
vertical at late time delay.
To further illustrate the increase in epidemic size that results from increased time delay,
Fig. 3 plots the probability distributions of combined final epidemic size E = EA + EB for two
coupled populations of 40 people each. City A has 39 initial susceptibles and one initial infective,
while city B is entirely susceptible. Five simulations are run with 15 susceptibles in each city
vaccinated at time delay τ = 1, 5, 10, 20, and 30 days, respectively. The cities have the same
coupling, fAB = 0.25, across all simulations. If vaccination were completely successful, the final
epidemic size should be at most 50. The probability of E > 50 is approximately zero if the cities
are vaccinated by 10 days, indicating successful vaccination. However, at a time delay of 20 days
or later, the large-scale epidemic peaks broaden, and P (E > 50) is nonzero. At τ = 20 days,
the tail of the large-scale epidemic peak in the probability distribution terminates at E ≈ 70.
This indicates that the disease may have spread to more than 50 individuals by the vaccination
date, leaving fewer than 30 susceptibles remaining and thereby resulting in potentially wasted
vaccine.
Tradeoffs Involving Time Delay, Available Vaccine, and Coupling
The level of interaction between individuals living in two different cities can affect the severity
of the combined epidemic size and the speed at which the infection spreads from the host city
to the other. The coupling fAB between city A and city B might be determined by spatial
separation and/or frequency of mass transportation. We now examine the affect of coupling
fAB and the ratio of vaccine allocated to each city, in addition to time delay τ and amount of
vaccine, on the final epidemic size.
The mean final epidemic sizes at two different values of time delay, τ = 1 day and τ = 10
days, are compared in Figs. 4A and 4B, which plot the mean final size 〈E〉 as a function of the
fractional vaccine allocation to city B and the coupling fAB. The color scale is kept the same
across all panels. The amount of available resources does not correspond to the actual fraction
of the population that is vaccinated, since for certain allocation protocols, some vaccines might
be wasted. For example, if there are 60 vaccines, enough to vaccinate 75% of the combined
population, allocating all available vaccine to city B, which has a population of 40, would result
in 20 wasted vaccines.
Vertical contours arise in the limiting case when, for a certain coupling, the final epidemic
size does not depend on the allocation of vaccine. On the other hand, horizontal contours arise
in the limit where the final epidemic size depends strongly on the vaccine allocation, but not on
the coupling.
For τ = 1, in the first panel of Fig. 4A, there are 10 available vaccines, or enough resources
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Figure 3. Probability distribution of combined final epidemic size in two coupled
populations. The probability distribution of E = EA + EB is plotted for two coupled
populations of 40 people each, with one initial infective in city A. The cities have coupling
fAB = 0.25 and are given 15 vaccines each (37.5% of the population) at varying values of time
delay τ . The chosen parameter values are r0 = 2 and γ = 0.15.
to vaccinate at most 12.5% of the population. In this case, the mean final epidemic size is
smallest when a majority of resources is allocated to city A, and when coupling is low. The
largest possible mean final size of 〈E〉 = 22 occurs when all vaccine is allocated to city B for
moderate coupling. This indicates that prophylaxis (i.e., preemptively vaccinating an uninfected
population) is not the best course of action; rather, very shortly after an outbreak, it is optimal
to deliver all available resources to the city where the outbreak has occurred, especially if the
cities are weakly coupled, in order to increase the chances of preventing the epidemic from
spreading to city B.
In the second panel, when 30 vaccines are available (enough for 37.5% of the population),
the contours are asymmetrical about the horizontal. For low fAB, the epidemic size is minimized
when most vaccine is given to city A, but as fAB increases, the minima occur for an increasingly
equal allocation. For larger amounts of vaccine, the preferred course of action is to allocate
equal amounts of vaccine to each city, except when fAB is extremely low, in which case an equal
allocation has roughly the same effect as one which allocates all vaccine to city A.
Contours of mean final epidemic size as a function of vaccine allocation and coupling for
τ = 10 days are plotted in Fig. 4B. In general, the final epidemic sizes are greater with the
increased time delay. When at most 12.5% of the total population can be vaccinated, the
contours are roughly vertical. Again, the smallest epidemic size for these parameters will occur
when all vaccine is given to city A for very low fAB, but for most values of fAB, the final size
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Figure 4. Tradeoffs involving coupling, time delay and available vaccine
represented by contours of combined final epidemic size. The mean final epidemic size
for two coupled cities 〈E〉 is plotted as a function of fractional vaccine allocation to city B and
coupling fAB for varying amounts of available vaccine at τ = 1 day (panel A) and τ = 10 days
(panel B). City A has 39 initial susceptibles and 1 infective; city B has 40 initial susceptibles.
The recovery rate γ = 0.15 and the reproductive number r0 = 2.
does not depend strongly on the allocation. In the remaining panels, the contours for larger
amounts of vaccine are more symmetrical about the horizontal than the corresponding plots for
τ = 1 day, and more often favor an equal allocation, rather than a protocol which disparately
allocates most vaccine to one city or another.
Optimal Vaccination Strategies
Optimal protocols were determined by minimizing the mean final epidemic size 〈E〉 in the
stochastic model, and the final epidemic size Edet in the deterministic model. For the stochastic
model, Fig. 5 plots all optimal allocations (expressed as the fraction allocated to city B) as a
function of available vaccine and coupling fAB. Each subplot is a snapshot taken at increasing
values of fixed time delay τ . Again, the simulations are of two cities, each containing 40 total
individuals, with one infected and the remaining susceptible in city A, and all susceptible in city
B.
The first panel describes the optimal protocol very early after the outbreak, when there is
a 1-day time delay. In this case, the optimal protocol allocates all resources to city A if the
available vaccine is low, unless coupling fAB is very high. In that event, a small fraction of
the vaccine should also be given to city B, since the cities are more well-mixed. As time delay
increases, completely favoring city A is optimal only for increasingly narrower ranges of weak
coupling and low vaccine. The contours decrease with vaccine roughly linearly as a function of
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Figure 5. Optimal vaccination strategies at different time delays. The optimal
fraction of total vaccine allocated to city B is plotted as a function of available vaccine
(expressed as a fraction of the total combined population) and coupling fAB for different fixed
values of time delay τ ranging from 1 to 60 days. City A has 39 initial susceptibles and 1
infective; city B has 40 initial susceptibles. The recovery rate γ = 0.15 and the reproductive
number r0 = 2.
coupling.
However, as τ increases to 20 days (the third panel), for moderately weak coupling 0.05 .
fAB . 0.25, the optimal protocol slightly favors city B, allocating 60% of available vaccine, while
equal allocation is preferred for most remaining scenarios. Since each city has approximately
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equal numbers of initial susceptibles, an equal allocation is the same as a proportional allocation.
At τ > 40 days, for weak coupling (fAB < 0.1), the optimal protocol favors city B, especially
when vaccine is low, indicating that the epidemic has begun to die out in city A while it is
growing in city B.
Fig. 6 contains the same information, except plotted as a function of time delay and coupling,
with snapshots taken at different amounts of available vaccine. In the first panel, for 12.5%
vaccination, there is high variability in the optimal protocols. For weak coupling, the optimal
protocol allocates almost all vaccine to city B at large time delay, indicating situations when
the epidemic has weakened considerably in city A and has spread to city B. However, for small
τ . 20, the optimal protocol allocates all vaccine to city A, regardless of coupling. At large
coupling, the optimal protocol is an equal allocation for τ > 20.
For greater amounts of vaccine, the contours remain a similar shape. As the available amount
of vaccine increases, the optimal protocols increasingly approach an equal allocation. In the last
panel, for 75% vaccination, the optimal protocol allocates vaccine equally for almost all τ and
fAB. The exceptions are a 30-40% allocation of vaccine to city B for small τ , and 60% allocation
of vaccine to city B for large τ and fAB < 0.1. These allocations correspond to one city receiving
42 vaccines and the other receiving 28. Since there are only 40 individuals in each city, at least
2 vaccines are wasted.
The deterministic model, in comparison, exhibits strikingly different results, as illustrated
in Figs. S1 and S2. Fig. S1 should be compared with Fig. 5, and Fig. S2 with Fig. 6. While
for low τ , the stochastic model tends to favor city A, the deterministic optimum is closer to an
equal allocation for most values of coupling and vaccine.
To directly compare the stochastic and deterministic models, we plot the difference between
the optimal fractions allocated to city B prescribed by the two models in Fig. 7. A positive
difference indicates that the deterministic model favors city B more heavily than the stochastic
model, and a negative difference indicates vice versa. We specifically highlight the case of 12.5%
vaccination, since lower vaccine leads to protocol differences further from zero.
In Fig. 7, the difference is always greater than −0.2 and for the most part positive. The
deterministic model generally allocates more vaccine to city B than the stochastic model, par-
ticularly for weak coupling and low vaccine. When τ and fAB are small, the deterministic model
completely favors city B, and the stochastic model completely favors city A, leading to a protocol
difference of 1. When fAB is large, the deterministic and stochastic models both favor an equal
allocation, so that the difference is 0. However, at large τ > 30 and small fAB, the difference is
negative. In this case, the stochastic model slightly favors city B compared to the deterministic
model, due to the asynchronous spread of infection and the longer temporal separation between
epidemic peaks at low coupling.
In general, the deterministic model requires a larger amount of vaccination to eradicate
the epidemic than in the stochastic model. In the deterministic model, the infection will always
spread from city A to city B if coupling is nonzero, whereas in the stochastic model, the infection
has a nonzero probability of terminating in city A. In the early stages of an epidemic, the
stochastic optimal protocol tends to favor city A, in order to decrease the likelihood of inter-city
transmission, rather than preemptively vaccinating city B. In contrast, the deterministic optimal
protocol tends to favor city B, in order to ultimately minimize final epidemic size. Furthermore,
in the stochastic model, as vaccination increases, the epidemic is more likely to be eradicated by
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Figure 6. Optimal vaccination strategies for different amounts of available vaccine.
The optimal fraction of total vaccine allocated to city B is plotted as a function of time delay τ
and coupling fAB for fixed vaccination amounts ranging from 10 to 60 vaccines. The remaining
parameters are the same as in Fig. 5.
stochastic extinction before the amount of vaccine required for herd immunity in a deterministic
model is reached [9].
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Figure 7. Difference between stochastic and deterministic optimal strategies. The
stochastic and deterministic models are compared by plotting the difference between optimal
fractions of vaccine allocated to city B for the case of 12.5% vaccination. City A has 39 initial
susceptibles and 1 infective; city B has 40 initial susceptibles. The recovery rate γ = 0.15 and
the reproductive number r0 = 2.
Worst-Optimal Differences
The worst-case vaccination protocol is defined as the vaccine allocation which results in the
maximum possible mean final epidemic size. In some cases, the mathematically worst-case
scenario results from common epidemic control strategies such as prophylaxis, particularly in a
region where the outbreak has not occurred, rather than sending vaccine to the active region
in order to mitigate the outbreak. The worst-case vaccination protocols are plotted for the
stochastic model in Fig. S3. The worst-case scenario will either result from allocating all vaccine
to city A or to city B, depending primarily on the time delay. When time delay is low (τ . 20
days), the worst-case protocol allocates all available vaccine to city B. When time delay is high,
the worst-case protocol allocates all vaccine to city A.
The difference in mean final epidemic size 〈E〉 between the optimal and worst-case scenarios,
or the worst-optimal difference, is plotted as a function of time delay and coupling for fixed values
of available vaccine in Fig. 8. The largest worst-optimal difference is about 〈E〉 = 14, or 17.5% of
the total combined population, and occurs for weak coupling, small time delay, and large amounts
of vaccine. This implies that optimal vaccination is most effective when administered early in
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an epidemic, since the infection will not have significantly propagated. This case corresponds
to an optimal allocation that tends to be relatively disparate in favoring one population over
another. The worst-optimal difference decreases as time delay and coupling increases, both
of which correspond to an enhanced spread of disease in city B. The worst-optimal difference
is almost non-existent for small time delay in well-mixed populations, or for large time delay
regardless of coupling. At large time delay, the epidemic has progressed to the point that the
worst-optimal difference is almost zero; strategic vaccination, or even vaccination at all, will be
mostly futile.
In contrast, the deterministic worst-case scenarios all result when vaccine is allocated entirely
to city A. The contours of the deterministic worst-optimal plot take on similar shapes as in the
stochastic plot, and the largest differences also occur for low time delay, low coupling, and
high vaccine. However, the maximum difference is about twice that of the stochastic result,
at about Edet = 30, or 37.5% of the population, compared to 17.5% in the stochastic model.
This suggests that the timing of the vaccination is more important in the stochastic model
than its allocation. The stochastic model is less sensitive to precise optimization of resource
allocation, but the stochastic optimal protocols (Fig. 6) depend more strongly on time than the
deterministic protocols (Fig. S2). The deterministic worst-optimal differences are plotted in Fig.
S5, while the worst-case resource allocation protocols are shown in Fig. S4.
To more closely examine the stochastic results, the mean final epidemic sizes 〈E〉 are plotted
in Fig. 9A as a function of the fraction of vaccine allocated to city B in the specific case of
τ = 5 and fAB = 0.05. Here, the difference in mean epidemic size between the worst-case and
optimal scenarios is relatively large, since time delay and coupling are both low. It is evident
that larger amounts of vaccine generally result in smaller mean epidemic sizes. When there is
enough vaccine for 12.5% of the population, the minimum of the line occurs when no vaccines
are given to city B. The minimum shifts rightward as the amount of vaccine increases; when
there is enough vaccine for 87.5% of the population, the minimum occurs for a 0.5 fractional
allocation. Note that the maxima always occur for all vaccine allocated to city B.
It is possible for a smaller amount of vaccine to more efficiently reduce final epidemic size
when allocated strategically than a larger amount of vaccine that is improperly used. If the
worst-case protocol is followed when there are 40 or greater vaccines (50% or more), all vaccines
would be allocated to city B, and at most 40 individuals, or the entire population of city B,
can be vaccinated. Any remaining vaccine would be wasted. This would result in a mean final
epidemic size 〈E〉 ≈ 15. However, when the optimal protocol is followed for 20 vaccines (25%),
all 20 vaccines are given to city A, and 〈E〉 ≈ 11, less than the previously described case.
Even though fewer individuals are vaccinated, fewer individuals become infected. Targeting the
source of the outbreak in order to minimize the chance of infection spreading elsewhere is a
better strategy than preemptively vaccinating those who do not live nearby.
The specific cases of 25% and 50% vaccination are highlighted in Fig. 9B, where the individual
mean final epidemic sizes 〈EA〉 and 〈EB〉 are plotted alongside the combined mean final epidemic
size. The epidemics are predictably smaller in city B. For both cases, 〈EA〉 monotonically
increases as a function of the vaccine allocated to city B, while 〈EB〉 monotonically decreases
as a function of vaccine allocation. 〈E〉 is also monotonic for 25% vaccination; however, 〈E〉 for
50% vaccination is non-monotonic, with a minimum that lies at around 0.3 fractional allocation.
For the parameter space explored so far in this paper, 〈EA〉 is minimized for vaccine alloca-
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Figure 8. Difference between optimal and worst-case final epidemic sizes. The
difference in stochastic mean final epidemic size between worst-case and optimal protocols is
plotted as a function of time delay τ and coupling fAB for increasing amounts of available
vaccine. The remaining parameters are the same as in Fig. 7.
tions that give all or most vaccine to city A, and 〈EB〉 is minimized for vaccine allocations that
give all or most vaccine to city B. That is, it is never beneficial for an individual population
to donate the majority of its vaccines to another population, even if the outbreak is occurring
elsewhere. This is also true for the deterministic model. However, for both populations viewed
as a whole, vaccine donating or vaccine sharing is often desirable.
For unequal population sizes, it is possible for both city A and city B to individually benefit
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Figure 9. Mean final epidemic size as a function of the fraction of vaccine
allocated to city B. The stochastic combined mean final epidemic size 〈E〉 as a function of
the fractional allocation to city B is plotted in (a) for different fixed amounts of available
vaccine. The specific cases of 25% and 50% vaccination are highlighted in (b), where mean
final epidemic sizes for individual populations 〈EA〉 and 〈EB〉 are also plotted, in addition to
the combined final size 〈E〉 = 〈EA〉+ 〈EB〉. The time delay is set to τ = 5 days and the
coupling fAB = 0.05. City A has 39 initial susceptibles and 1 infective; city B has 40 initial
susceptibles. The recovery rate γ = 0.15 and the reproductive number r0 = 2.
when all vaccine is given to city A, provided that city A is relatively small compared to city B
and time delay and coupling are very low. In this case, the probability of infection spreading
from A to B is low, such that a relatively small amount of vaccine will be effective at mitigating
the infection in city A. Thus, it is reasonably safe for B to remain vulnerable and instead focus
efforts on eradicating the epidemic in city A. This case is illustrated in Fig. 10, where there
are now 20 individuals (one of which is infected) in city A and 100 susceptibles in city B. The
individual mean final epidemic sizes 〈EA〉 and 〈EB〉 are both minimized when all 10 available
vaccines are allocated to city A.
Discussion
Using an SIR model to simulate epidemics in interacting populations, we analyzed the tradeoffs
involving vaccination, time delay, and coupling in order to determine optimal resource allocation
strategies. The earlier a population undergoes mass vaccination, the more effective the inter-
vention, and less vaccine will be required to eradicate the epidemic. For interacting cities, the
optimal solution might favor one city over another, depending on the time delay until vaccine is
deployed. In general, weaker coupling leads to protocols which allocate vaccine in more disparate
proportions to the two cities, while stronger coupling favors protocols which allocate vaccine in
equal (and proportional) amounts to each city.
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Figure 10. A case in which both cities benefit the most when all vaccine is
allocated to city A. The combined mean final epidemic size 〈E〉 and the individual mean
final sizes 〈EA〉 and 〈EB〉 are minimized when all vaccines are allocated to city A in order to
eradicate the infection at its source, due to the low coupling (fAB = 0.01) and low time delay
(τ = 5). 10 vaccines are given to city A, which has a population of 20 individuals, while city B,
which has a population of 100, remains completely susceptible.
Synchrony
A useful quantity to examine is synchrony, a measure of the correlation between the infection
dynamics of interacting populations, which increases as a function of coupling. This relationship
between correlation and coupling is demonstrated for the specific case of τ = 5 and 25% vac-
cination in 11A. Here, correlation is defined as the Pearson correlation coefficient between the
number of infectives in each city, IA(t) and IB(t), as measured over a full simulation. Synchrony
also affects the optimal vaccine allocation; higher synchrony tends to result in a more equal
division of vaccine between the two cities, while lower synchrony tends to result in a less equal
allocation.
The effects of vaccination on synchrony can depend on the specific parameters of the disease.
In general, vaccination increases the probability of disease extinction while also reducing the
effective coupling, since transmission is decreased. Reduced coupling leads to reduced synchrony,
which in turn reduces the probability of permanent widespread extinction: asynchrony across
spatial scales increases the probability that infection will return to a population where the
disease was previously eradicated, in what is termed a “rescue event” [9]. It has been observed
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Figure 11. Synchrony of epidemics represented by correlation and lag time as
function of coupling. A: The correlation between the number of infectives I(t) in each city
is plotted as a function of coupling fAB. Higher correlation corresponds to higher synchrony.
B: The lag time between epidemics is plotted as a function of fAB. A lower lag time
corresponds to higher synchrony. For both plots, 25% of the total combined population is
vaccinated after 5 days in an equal allocation, such that each city receives 10 vaccines. City A
has 39 initial susceptibles and 1 infective; city B has 40 initial susceptibles. The recovery rate
γ = 0.15 and the reproductive number r0 = 2.
(for example, during the measles outbreak in England and Wales in the 1970s and 19780s) that
the effects of reduced infection due to vaccination approximately cancel those of asynchrony [9].
However, Rohani et al. [22] comprehensively compared measles and pertussis outbreaks in
England and Wales between 1940 and 1990, finding that while vaccination decreased synchrony
of measles outbreaks, it actually increased synchrony of pertussis outbreaks. This was attributed
to the relatively longer pertussis infection period, as well as the increased age at vaccination for
pertussis, which implies increased individual movement and therefore increased coupling.
Pulsed vaccination, in which the population is vaccinated periodically over a specified time-
frame, in conjunction with steady mass vaccination, has been suggested as a method to syn-
chronize epidemics, thereby more effectively controlling the disease [23]. Pulsed vaccination is
particularly useful for vaccinating children with an immunization course administered over a
certain age range.
Large time delay and low coupling contribute to asynchrony, as illustrated in the first panel
of Fig. 6. When fAB . 0.25 and τ & 30, the optimal allocation highly favors city B. At this
late point in the epidemic, the infection has begun to die out in city A but has started to grow
in city B, due to a lag time between the epidemics in each city. We define the mean lag time
as the mean difference in time between when the number of infectives IA(t) in city A reaches
a maximum and when IB(t) in city B reaches a maximum. The mean lag time decreases as a
function of coupling, as illustrated in Fig. 11B, since higher coupling results in more synchronous
epidemics. If there is a localized outbreak in city A, the increased lag time at low coupling could
22
be relatively advantageous to city B by effectively buying time for vaccine to be transported and
administered to city A.
Broader Implications
While the communities simulated in this paper are relatively small, we have qualitatively il-
lustrated tradeoffs that we expect to be important at larger scales, including at the level of
entire nations. For example, if resources have been stockpiled, it can be undesirable to keep
all vaccines within a nation, especially if frequent international travel encourages the spread of
infection. On the other hand, if coupling is extremely low, vaccinating an uninfected population
while an outbreak occurs elsewhere can be disadvantageous. Rather, exporting vaccine to the
location of the outbreak in order to localize the spread of the infection could more effectively
reduce its severity.
Even for large populations, there can be a significant probability that the disease does not
propagate between cities or countries. Should the amount of available vaccine be limited, it
can be disadvantageous, from a holistic perspective, for an uninfected population to vaccinate
itself when an epidemic is occurring in another population. As described in Fig. 9, vaccinating
the uninfected population preemptively can lead to more severe epidemics. Vaccine is typically
allocated in proportion to regional population sizes, as with the H1N1 vaccine within the United
States during the 2009 epidemic [24]. When the disease is widespread, this is likely the optimal
solution, but if the infection is relatively localized, it might be favorable to focus on eradicating
the disease near its source.
The model described in this paper is based on the basic SIR framework, but it can readily
be made more complex by adding compartments, such as an E class representing exposed
individuals who are symptomatic but not infectious. Other variants on the SIR model include,
for example, the SIRS model, in which a recovered individual stays immune for some finite
amount of time before reverting to susceptibility, or the SIS model, which skips the recovery
stage altogether. The choice of model will be dictated by the characteristics of the specific
disease being studied.
The methods detailed in this paper can also be applied to a more realistic model incorporat-
ing, for instance, different rates of infection based on age. Spatial separation and heterogeneity
could be explicitly included, as well as specific logistic considerations such as delays due to
transport of vaccine from storage facilities to clinics. Other forms of epidemic control can be in-
cluded, such as transportation restrictions or quarantining. Restricting transportation between
cities will reduce the effective coupling f and reduce the overall movement of individuals. Quar-
antining serves to reduce the effective infection period 1/γ by isolating infectives from the rest
of the population [9]. Quarantine effectively dampens the infectious spread and is an attractive
method of epidemic control, since it does not involve the high costs of producing and distributing
vaccine. However, unlike vaccination, quarantine does not directly immunize susceptibles, but
indirectly protects them by lowering the probability of transmission.
Moreover, while we do not consider them in this paper, SIR models on networks are also
commonly used to model epidemics and are especially useful for understanding spatial dynamics.
An example SIR network model could have cities defined on nodes with edge weights derived
from transportation frequency, such as in the model devised by Matrajt et al [19]. In this
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model, the spread of infection within cities is described with the deterministic SIR equations,
while interactions between cities is described by a stochastic process. While this hybrid model
includes the probability of non-spreading, the deterministic intra-city interactions do not account
for the variability of the disease dynamics and the probability of early disease extinction within
a community.
The problem of optimizing dynamic resource allocation can be also be applied to natural
disasters, oil spills, and other circumstances which are of interest to policy officials. SIR-type
models similar to those formulated in this paper can in particular be applied to wildfires, with
compartments of unburned, burning, and burned corresponding to susceptible, infected, and
recovered, respectively [25]. While the concept of coupled populations in epidemiology does
not have a direct analogy in the realm of natural disasters, wildfires may break out in rapid
succession in different areas, requiring quick and optimized allocation of resources.
The difference between the outcomes of optimal and worst-case scenarios can be compared
to identify where intervention is most effective. Furthermore, it may not be preferred to follow
the optimal protocol in certain cases. For example, if the optimal solution prescribes vaccinating
only city A, leaving city B’s populace fully vulnerable to the infection is likely unfavorable to
the residents of city B, especially since the probability of the epidemic spreading to city B is
nonzero. In such a case, policymakers could take the worst-optimal difference into consideration
to choose a vaccination protocol such that a middle ground is struck between a mathematically
optimal solution and a realistic, but not excessively deleterious, solution.
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Supporting Information
Algorithmic considerations
In this paper, we used a stochastic SIR framework to model the spread of an epidemic between
two interacting cities, performing numerical integration with the implicit-Euler (IE) method [10].
An alternative method, Krylov subspace approximation (KSA), can also be applied to the master
equation; KSA is commonly used to simplify Markov chains containing exponentials of large,
sparse matrices [26]. The KSA method uses a small, dense matrix to efficiently approximate
solutions to the master equation, rather than directly integrating with the generator matrix
itself. The master equation can be written as the recursive series of equations:
~P (ti) = exp(τA)~P (ti−1), (20)
which can then be solved using, for instance, the Expokit package in MATLAB [27]. The
approximate solutions take the form:
~P (ti) = ||~P (ti−1)||2 V(ti−1) exp{τH(ti−1)} eˆ1, (21)
where the columns of V form an orthonormal basis of the m-dimensional Krylov subspace:
Km(t) = span{~P (t), τA~P (t), . . . , (τA)
m−1 ~P (t)}. (22)
H is a dense m × m upper-Hessenberg matrix, generated using the Arnoldi method, which
satisfies:
V
TτAV = τH, (23)
and eˆ1 is the first column of the m-dimensional identity matrix. Because m << K, where K is
the dimension of A, the upper-Hessenberg matrix H is much smaller than A.
The accuracy of the IE method is controlled by the size of the time step, which is chosen
by the user; the error of the IE method is O(τ). On the other hand, the accuracy of the
KSA method is controlled by the size of the Krylov subspace and the Expokit error tolerance,
both of which are specified by the user. Furthermore, the KSA method is prone to instabilities
arising from compounded errors, and occasionally cannot produce a normalized, nonnegative
probability vector without resorting to a heuristic approximation. In general, the KSA method
is less computationally intensive than the IE method with the chosen time step size, but also
less accurate.
A 200-day simulation of two cities with 40 people each, 0.25 coupling, and 40 vaccines
administered at a 10 day delay, executed in MATLAB 8.5 on a 2.5 GHz Intel Core i7 processor,
took 874 seconds with the IE method using a time step of 0.01 seconds. In comparison, the
same simulation took 344 seconds with the KSA method using a Krylov subspace of dimension
65 and an Expokit error tolerance of 1 × 10−3. An “exact” solution was generated by running
the KSA method with a subspace of dimension 85 and an error tolerance of 1×10−7, which took
440 seconds. The results generated with the IE and KSA methods were compared to the exact
solution and had L2 errors of order 10−4 and 10−2, respectively. While the time required to
run the “exact” KSA simulation is about half that required for the IE method, the IE method
allows for greater control of the integration process. The time steps are smaller and uniform in
size and allow for more temporal dynamics to be extracted.
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Figure S1. Deterministic optimal strategies at different time delays. The optimal
fraction of total vaccine allocated to city B in the deterministic model is plotted as a function
of available vaccine (expressed as a fraction of the total combined population) and coupling
fAB for different fixed values of time delay τranging from 1 to 60 days.
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Figure S2. Deterministic optimal strategies for different amounts of available
vaccine. Optimal fraction of total vaccine allocated to city B in the deterministic model
plotted as a function of time delay τ and coupling fAB for different fixed values of available
resources ranging from 10 to 60 vaccines (i.e. 12% to 75% vaccination).
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Figure S3. Worst-case vaccine allocations in the stochastic model. The vaccine
allocations resulting in maximum mean final epidemic size 〈E〉max are plotted as a function of
time delay τ and coupling fAB for different fixed amounts of available vaccine. City A has 39
initial susceptibles and one infective; city B has 40 initial susceptibles. The recovery rate
γ = 0.15 and the reproductive number r0 = 2.
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Figure S4. Worst-case vaccine allocations in the deterministic model. The vaccine
allocations resulting in maximum final epidemic size Emaxdet are plotted as a function of time
delay τ and coupling fAB for different fixed amounts of available vaccine. City A has 39 initial
susceptibles and one infective; city B has 40 initial susceptibles. The recovery rate γ = 0.15
and the reproductive number r0 = 2.
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Figure S5. Difference between deterministic optimal and worst-case final epidemic
sizes. The difference in deterministic final epidemic size Edet between worst-case and optimal
protocols is plotted as a function of time delay τ and coupling fAB for different fixed amounts
of available vaccine.
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